[Effect of penicillin and D-penicillamine on beta-galactosidase activity in patients with progressive scleroderma].
Schulze
E
E
Herrmann
K
K
Haustein
U F
UF
Krusche
U
U
Rothenburger
I
I
D004305:Dose-Response Relationship, Drug; D005696:Galactosidases / Q000037:antagonists & inhibitors*; D006801:Humans; D008099:Liver / Q000201:enzymology; D010396:Penicillamine / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000201:enzymology; D001616:beta-Galactosidase / Q000037:antagonists & inhibitors*
D010406:Penicillins; D005696:Galactosidases; D001616:beta-Galactosidase; D010396:Penicillamine
Einfluss von Penicillin und D-Penicillamin auf die beta-Galactosidaseaktivität bei Patienten mit progressiver Sklerodermie.